Skip to content
TrialScanner

NCT05814757

OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)

Phase 2CompletedOCULLead

Registry record

Lead sponsor
Ocular Therapeutix, Inc.
Conditions
Dry Eye Syndromes; Eye Diseases
Primary completion
May 22, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05814757 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05814757: OTX-DED for the Short-term... | TrialScanner